Apigenin

Apigenin has been studied in 359 papers since 1990: 5 trials and 6 observational studies in people, 143 in animals, 102 in cells, 91 reviews; 23 in the past year. Its furthest trials in people are at phase 1/2. The newest paper, Oct 7, 2026: “Is there a role for senotherapeutics in the treatment of giant cell arteritis?”.

InterventionPhase 1/2

359 papers study it9 more mention it123 findingsUpdated

PubChemChEBIMeSH

Part of Andrew Huberman's Toolkit for SleepMore supplements

1 new paper in 30 daysSee all 83 papers on apigenin

At a glance

Apigenin extends lifespan in worms and flies; independent labs reproduce reduced bone loss in mice and senescence-associated secretory phenotype in human cells. One group links apigenin with lower PhenoAgeAccel in humans, while animal results differ on oxidative stress and obesity. Some authors are affiliated with Nemoto, and the National Natural Science Foundation of China funds much of this work.

123 findings in 47 papers from 2008 to 2026, 5 of them since May 2026

The findings reach people, from one lab or study; independent labs found the same change in cells, worms or flies and mice. 34 independent labs in 10 countries; 1 trial, none about aging, 1 with no results posted.

“Similar inverse associations were observed for apigenin (Q4 vs Q1: OR = 0.647, P = .002)”
Associations of dietary flavones, particularly apigenin and luteolin, with phenotypic age acceleration: A cross-sectional study using NHANES dataMedicine2025doi:10.1097/md.0000000000046520

2 of its findings point the other way.

Cells, worms or flies and mice: replicated by independent labs. Humans: a single group.
  • 34 independent labs in 10 countries
  • 2 findings against
  • 1 trial, none about aging, 1 with no results posted
  • Funders: National Natural Science Foundation of China and others
  • 3 of 109 findings with company ties
  • Humans4
  • Animals30
  • Model organisms7
  • Cells7

What did studies of apigenin find?

90

Studies of apigenin measured 90 outcomes, among them lifespan, senescence-associated secretory phenotype (SASP) and oxidative stress and ROS signaling.

Lifespan

upin flies2upin worms2upin mice1upin yeast cells1

5 studies
  1. Apigenin extends lifespan in worms.

    “chronic exposure to apigenin extended median lifespan”

    Model organisms

    Apigenin Improves Healthspan and Protects Against Alzheimer's Disease-Associated Proteotoxicity in C. elegans

    bioRxivPreprint

  2. Apigenin extends lifespan in mice (28Si-irradiated) (63% vs 37%).

    “At 770 days, survival rates were 37% for 28Si-exposed mice and 63% for those consuming AP, despite irradiation.”

    Animals28Si-irradiateddiet20 mg/kg body weightfive days before and after total-body irradiationmales

    Daily Consumption of Apigenin Prevents Acute Lymphoma/Lymphoblastic Leukemia in Male C57BL/6J Mice Exposed to Space-like Radiation

    Cancers

  3. Apigenin extends lifespan in flies.

    “as well as longevity in male and female flies”

    Model organisms

    Apigenin enhancing oxidative resistance and proteostasis to extend lifespan via PTEN-mediated AKT signalling pathway

    Biochimica et biophysica acta. Molecular basis of disease

  4. Apigenin extends lifespan in yeast cells.

    “apigenin significantly extends both replicative and chronological life duration in yeast”

    Cells

    Apigenin enhancing oxidative resistance and proteostasis to extend lifespan via PTEN-mediated AKT signalling pathway

    Biochimica et biophysica acta. Molecular basis of disease

  5. Apigenin extends lifespan in worms.

    “We identified chrysin and apigenin, which reduced ATP production and increased the lifespan of worms.”

    Model organisms

    Transient inhibition of mitochondrial function by chrysin and apigenin prolong longevity via mitohormesis in C. elegans

    Free radical biology & medicine

  6. Apigenin extends lifespan in flies (transgenic model expressing human alpha-synuclein in the brain).

    “The flies showed an increase in life span, glutathione, and dopamine content.”

    Model organismstransgenic model expressing human alpha-synuclein in the braindietbrain24 days

    Alteration in biochemical parameters in the brain of transgenic Drosophila melanogaster model of Parkinson's disease exposed to apigenin

    Integrative medicine research

Senescence-associated secretory phenotype (SASP)

downin human cells2downin reviews2downin cells1

5 studies
  1. Apigenin decreases senescence-associated secretory phenotype (SASP) in cells (LPS-exposed macrophages).

    “API inhibits DOT1L-mediated H3K79me2 enrichment to downregulate IL1A, thus reducing the SASP of macrophages.”

    CellsLPS-exposed macrophagesmacrophage

    Targeting senescence-associated secretory phenotype macrophage: apigenin inhibits DOT1L-dependent H3K79me2 at IL1A to fight SASP in senescent macrophages

    Frontiers in molecular biosciences

  2. Apigenin inhibits senescence-associated secretory phenotype (SASP) (senescent cells).

    “Specifically, it suppresses the senescence-associated secretory phenotype (SASP) by inhibiting key inflammatory signaling pathways such as NF-κB and p38-MAPK”

    Reviewsenescent cells

    Apigenin as a bioactive compound for longevity: Targets and mechanisms in senescent cells

    Bioactive Compounds in Health and Disease

  3. Apigenin prevents senescence-associated secretory phenotype (SASP) in human cells.

    “In senescent cells, apigenin blocks the interactions between ATM/p38 and HSPA8, thus preventing transition of the acute stress-associated phenotype (ASAP) towards the SASP.”

    Cells

    Repurposing the plant-derived compound apigenin for senomorphic effect in antiaging pipelines

    bioRxiv (Cold Spring Harbor Laboratory)Preprint

  4. Apigenin inhibits senescence-associated secretory phenotype (SASP).

    “Naturally occurring agents such as apigenin and kaempferol inhibit SASP.”

    Review

    Emerging role of cellular senescence in the pathogenesis of oral submucous fibrosis and its malignant transformation

    Head & neck

  5. Apigenin decreases senescence-associated secretory phenotype (SASP) in senescent human fibroblasts.

    “apigenin suppresses the SASP in three human fibroblast strains induced to senesce by ionizing radiation, constitutive MAPK (mitogen-activated protein kinase) signaling, oncogenic RAS, or replicative exhaustion”

    Cellsin senescent human fibroblasts

    Apigenin suppresses the senescence-associated secretory phenotype and paracrine effects on breast cancer cells

    GeroScience

More on Senescence-associated secretory phenotype (SASP)

Oxidative stress and ROS signaling

downin flies2downin human cells1downin mice1upin worms1

5 studies
  1. Apigenin decreases oxidative stress and ROS signaling in human cells (OP-BMSCs).

    “reduced OP-BMSCs' reactive oxygen species (ROS) levels”

    CellsOP-BMSCs

    An Apigenin-Based Bone-Targeted System Enhances Antioxidant Capacity of Bone Marrow Mesenchymal Stem Cells via the PI3K/Akt Pathway to Alleviate Osteoporosis

    ACS biomaterials science & engineering

  2. Apigenin decreases oxidative stress and ROS signaling in flies.

    “Apigenin treatment also improves resistance to oxidative stress in both organisms”

    Model organisms

    Apigenin enhancing oxidative resistance and proteostasis to extend lifespan via PTEN-mediated AKT signalling pathway

    Biochimica et biophysica acta. Molecular basis of disease

  3. Apigenin decreases oxidative stress and ROS signaling in mice (4-vinylcyclohexene diepoxide-induced perimenopausal syndrome).

    “High concentration of apigenin significantly reversed the alteration induced by VCD.”

    Animals4-vinylcyclohexene diepoxide-induced perimenopausal syndromeovaryHigh concentration

    Apigenin Improves Ovarian Dysfunction Induced by 4-Vinylcyclohexene Diepoxide via the AKT/FOXO3a Pathway

    Cell biochemistry and function

  4. Apigenin induces oxidative stress and ROS signaling in worms.

    “Apigenin induced the oxidative stress response and lipid mobilization”

    Model organisms

    Phenolic Compounds Reduce the Fat Content in Caenorhabditis elegans by Affecting Lipogenesis, Lipolysis, and Different Stress Responses

    Pharmaceuticals (Basel, Switzerland)

  5. Apigenin decreases oxidative stress and ROS signaling in transgenic Drosophila model of PD.

    “reduced the oxidative stress as well as apoptosis in transgenic Drosophila model of PD”

    Model organismsin transgenic Drosophila model of PDdietbrain24 days

    Alteration in biochemical parameters in the brain of transgenic Drosophila melanogaster model of Parkinson's disease exposed to apigenin

    Integrative medicine research

More on Oxidative stress and ROS signaling

Cellular senescence

downin cells1downin mice1downin mouse cells1

3 studies
  1. Apigenin decreases cellular senescence in cells (LPS-exposed macrophages).

    “API treatment effectively reduced cellular senescence in LPS-exposed macrophages.”

    CellsLPS-exposed macrophagesmacrophage

    Targeting senescence-associated secretory phenotype macrophage: apigenin inhibits DOT1L-dependent H3K79me2 at IL1A to fight SASP in senescent macrophages

    Frontiers in molecular biosciences

  2. Apigenin decreases cellular senescence in HFD-fed mice.

    “It also decreased senescence markers (p16, p21, and γH2AX) in liver tissues”

    Animalsin HFD-fed miceliver

    Apigenin attenuates hepatocyte senescence in metabolic dysfunction-associated steatotic liver disease by targeting the TGF-β signaling pathway

    Cytotechnology

  3. Apigenin decreases cellular senescence in vitro.

    “apigenin reduced markers of inflammation and cellular senescence in these cells”

    Cellsin vitroastrocyte

    Protective effects of apigenin on the brain transcriptome with aging

    Mechanisms of ageing and development

More on Cellular senescence

Inflammation

downin mouse cells1downin reviews1downin zebrafish1

3 studies
  1. Apigenin decreases inflammation in zebrafish.

    “apigenin, genistein, and hesperetin exhibited notable anti-inflammatory activity”

    Animals

    Synergizing Virtual Screening and Zebrafish Models to Identify Resveratrol-Derived Antiaging Polyphenols

    Pharmaceuticals (Basel, Switzerland)

  2. Apigenin inhibits inflammation.

    “This review explores the potential of apigenin as an anti-inflammatory agent across diverse neurological conditions”

    Review

    Exploring the Role of Apigenin in Neuroinflammation: Insights and Implications

    International journal of molecular sciences

  3. Apigenin decreases inflammation in vitro.

    “apigenin reduced markers of inflammation and cellular senescence in these cells”

    Cellsin vitroastrocyte

    Protective effects of apigenin on the brain transcriptome with aging

    Mechanisms of ageing and development

More on Inflammation

Apoptosis

downin mice2downin flies1

3 studies
  1. Apigenin decreases apoptosis in mice (4-vinylcyclohexene diepoxide-induced perimenopausal syndrome).

    “Apigenin alleviated VCD-induced cell apoptosis through regulating Bax, Bcl-2, cleaved PARP1 and caspase-3.”

    Animals4-vinylcyclohexene diepoxide-induced perimenopausal syndromeovary

    Apigenin Improves Ovarian Dysfunction Induced by 4-Vinylcyclohexene Diepoxide via the AKT/FOXO3a Pathway

    Cell biochemistry and function

  2. Apigenin decreases apoptosis in mice (measured as DNA fragmentation in aged mice with skeletal muscle atrophy).

    “The data also suggested that apigenin inhibited Bcl-2/adenovirus E1B 19kD-interacting protein 3 and DNA fragmentation as indicators of mitophagy and apoptosis”

    Animalsmeasured as DNA fragmentation in aged mice with skeletal muscle atrophyskeletal muscle

    Antioxidant Apigenin Relieves Age-Related Muscle Atrophy by Inhibiting Oxidative Stress and Hyperactive Mitophagy and Apoptosis in Skeletal Muscle of Mice

    The journals of gerontology. Series A, Biological sciences and medical sciences

  3. Apigenin decreases apoptosis in transgenic Drosophila model of PD.

    “reduced the oxidative stress as well as apoptosis in transgenic Drosophila model of PD”

    Model organismsin transgenic Drosophila model of PDdietbrain24 days

    Alteration in biochemical parameters in the brain of transgenic Drosophila melanogaster model of Parkinson's disease exposed to apigenin

    Integrative medicine research

More on Apoptosis

Cell proliferation

downin human cells2downin mouse cells1

3 studies
  1. Apigenin decreases cell proliferation in human cells (paracrine effects of senescent cells on breast cancer cells).

    “apigenin-mediated suppression of the SASP substantially reduced the aggressive phenotype of human breast cancer cells, as determined by cell proliferation, extracellular matrix invasion, and epithelial-mesenchymal transition”

    Cellsparacrine effects of senescent cells on breast cancer cells

    Apigenin suppresses the senescence-associated secretory phenotype and paracrine effects on breast cancer cells

    GeroScience

  2. Apigenin decreases cell proliferation in human cells.

    “luteolin and apigenin inhibited cell proliferation”

    Cellsdental pulp cells

    Effect of luteolin and apigenin on the expression of Oct-4, Sox2, and c-Myc in dental pulp cells with in vitro culture

    BioMed research international

  3. Apigenin inhibits cell proliferation in MC3T3-E1 cells.

    “Apigenin markedly inhibited cell proliferation and indices of osteoblast differentiation, such as collagen production, alkaline phosphatase activity, and calcium deposition in osteoblastic MC3T3-E1 cells”

    Cellsin MC3T3-E1 cells1-10 μM

    Apigenin inhibits osteoblastogenesis and osteoclastogenesis and prevents bone loss in ovariectomized mice

    Cytotechnology

Obesity

no changein rats1downin reviews1

2 studies
  1. Apigenin showed no clear effect on obesity in rats (High-calorie diet-fed Wistar rats; concurrent preventive treatment).

    “preemptive Api treatment failed to prevent obesity”

    AnimalsHigh-calorie diet-fed Wistar rats; concurrent preventive treatment50 mg/kg88 daysmales

    Oral apigenin prevents obesity-related muscular atrophy, but not obesity itself, in middle-aged rats fed a high-calorie diet

    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

  2. Apigenin decreases obesity.

    “Anti-obesity activity of apigenin is mainly through attenuating adipocyte differentiation by suppressing the mitotic clonal expansion and the adipogenesis-related factors.”

    Review

    Role of apigenin in targeting metabolic syndrome: A systematic review

    Iranian journal of basic medical sciences

More on Obesity

Frailty

downin mice2

2 studies
  1. Apigenin decreases frailty in animals with a premature aging-like state.

    “alleviating physical frailty and cognitive impairment”

    Animalsin animals with a premature aging-like state

    Targeting Senescence with Apigenin Improves Chemotherapeutic Efficacy and Ameliorates Age-Related Conditions in Mice

    Advanced science (Weinheim, Baden-Wurttemberg, Germany)

  2. Apigenin decreases frailty in mice (dose-dependent effect in aged mice with age-related muscle atrophy).

    “apigenin showed significant dose-dependent effects in relieving aging-related muscle atrophy according to results of frailty index”

    Animalsdose-dependent effect in aged mice with age-related muscle atrophymales

    Antioxidant Apigenin Relieves Age-Related Muscle Atrophy by Inhibiting Oxidative Stress and Hyperactive Mitophagy and Apoptosis in Skeletal Muscle of Mice

    The journals of gerontology. Series A, Biological sciences and medical sciences

Physical function

upin animals1upin mice1

2 studies
  1. Apigenin improves physical function in animals with a premature aging-like state.

    “apigenin improves the physical function of animals with a premature aging-like state, alleviating physical frailty and cognitive impairment”

    Animalsin animals with a premature aging-like state

    Targeting Senescence with Apigenin Improves Chemotherapeutic Efficacy and Ameliorates Age-Related Conditions in Mice

    Advanced science (Weinheim, Baden-Wurttemberg, Germany)

  2. Apigenin improves physical function in animals after whole body irradiation-induced premature aging.

    “In preclinical trials, apigenin administration improves physical function of animals prematurely aged after whole body irradiation, alleviating physical frailty and cognitive impairment.”

    Animalsafter whole body irradiation-induced premature aging

    Repurposing the plant-derived compound apigenin for senomorphic effect in antiaging pipelines

    bioRxiv (Cold Spring Harbor Laboratory)Preprint

All 90

What is apigenin linked with?

3

Studies link apigenin with 3 measures: accelerated biological aging, TFRC and cancer.

Accelerated biological aging

downin humans1

1 study
  1. Apigenin is linked with a lower risk of accelerated biological aging in humans (cross-sectional association with KDM and PhenoAge definitions).

    “Daidzein, apigenin, magnesium, zinc, and vitamin E are core dietary antioxidants closely associated with a reduced risk of accelerated biological aging.”

    Humanscross-sectional association with KDM and PhenoAge definitionsn = 8,125

    Interpretable machine learning with SHAP analysis identifies redox-modulating dietary antioxidants for predicting accelerated biological aging

    Experimental gerontology

TFRC

mixedin silico1

1 study
  1. Apigenin is associated with TFRC in silico (molecular docking and molecular dynamics simulations).

    “TFRC binds strongly to apigenin, metformin, menadione, and estradiol”

    In silicomolecular docking and molecular dynamics simulations

    Apigenin is a Potential Drug for Treating Ischemic Stroke. Association between Plasma Protein Genes and Ischemic Stroke: A Proteome-wide Mendelian Randomization Analysis and Experimental Study

    Current topics in medicinal chemistry

More on TFRC

Cancer

downin humans1

1 study
  1. Apigenin lowers the risk of cancer in humans.

    “Epidemiologic and case-control studies have suggested apigenin reduces the risk of certain cancers.”

    Review

    Plant flavone apigenin: An emerging anticancer agent

    Current pharmacology reports

More on Cancer

Has apigenin been tested in people?

0 of 1 about aging

Yes: 5 trials and 6 observational studies in people have been published, and 1 trial is registered.

In trials

Trial sponsors

How this record changed

  1. Summary rewritten as its findings changed.

    As it read before

    One preprint study in worms reports that apigenin extends lifespan, improves healthspan and reduces macromolecular damage accumulation, while decreasing functional impairments in models of Alzheimer’s disease-associated proteotoxicity.

  2. Summary written from the findings.

Latest

Dec 2025: 2Jan 2026: 1Feb 2026: 2Mar 2026: 5Apr 2026: 2May 2026: 1Jun 2026: 1Jul 2026: 2Aug 2026: 1Sep 2026: 2Oct 2026: 2Nov 2026: 021 papers in 12 months

See all 83 papers on apigenin